Clinical Trials Browser

Phase 1/2 × Breast Neoplasms, Male × Granulocyte Colony-Stimulating Factor × Clear all

NCT00063934 2019-03-05

Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer

Phase 1/2 Terminated

31 enrolled 8 charts

Breast Neoplasms, Breast Neoplasms, Male